Striatal GABA-MRS predicts response inhibition performance and its cortical electrophysiological correlates by Quetscher, Clara et al.
Striatal GABA-MRS predicts response inhibition performance 
and its cortical electrophysiological correlates
Clara Quetscher1,2, Ali Yildiz2, Shalmali Dharmadhikari3,4, Benjamin Glaubitz5, Tobias 
Schmidt-Wilcke5, Ulrike Dydak3,4, and Christian Beste1,2
1Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine 
of the TU Dresden, Germany
2Institute for Cognitive Neuroscience, Biopsychology, Ruhr-Universität Bochum, Germany
3School of Health Sciences, Purdue University, West Lafayette, USA
4Department of Radiology and Imaging Sciences, Indiana University School of Medicine, 
Indianapolis, USA
5Department of Neurology, Berufsgenossenschaftliche Kliniken Bergmannsheil, Ruhr-Universität 
Bochum, Germany
Abstract
Response inhibition processes are important for performance monitoring and are mediated via a 
network constituted by different cortical areas and basal ganglia nuclei. At the basal ganglia level, 
striatal GABAergic medium spiny neurons are known to be important for response selection, but 
the importance of the striatal GABAergic system for response inhibition processes remains 
elusive. Using a novel combination of behavioural, EEG and magnetic resonance spectroscopy 
(MRS) data we examine the relevance of the striatal GABAergic system for response inhibition 
processes. The study shows that striatal GABA levels modulate the efficacy of response inhibition 
processes. Higher striatal GABA levels were related to better response inhibition performance. We 
show that striatal GABA modulate specific subprocesses of response inhibition related to pre-
motor inhibitory processes through the modulation of neuronal synchronization processes. To our 
knowledge this is the first study providing direct evidence for the relevance of the striatal 
GABAergic system for response inhibition functions and their cortical electrophysiological 
correlates in humans.
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Introduction
Response inhibition processes are important for cognitive control (for review: Bari & 
Robbins, 2013). Several lines of research using functional imaging in humans, clinical data 
as well as animal studies have shown that prefrontal cortical areas, like the dorsolateral 
prefrontal cortex (e.g. Hester et al., 2004), pre- and supplementary motor areas (pre-SMA, 
SMA) (e.g. Isoda & Hikosaka, 2007; Mostofsky et al., 2003; Simmonds et al., 2003), the 
inferior frontal cortex (e.g. Aron et al., 2004) and the anterior cingulate cortex (e.g. Rubia et 
al., 2001) are part of the response inhibition network. The response inhibition network also 
includes subcortical nuclei, which are hypothesized to receive stop commands from cortical 
structures used to incept or withhold a response (Duann et al., 2009). It has been shown that 
besides the subthalamic nucleus (e.g. Forstmann et al., 2012; van den Wildenberg et al., 
2006), the striatum is important in response inhibition (e.g. Boehler et al., 2010; Beste et al., 
2010). The striatum contains GABAergic medium spiny neurons (MSNs) (Bolam et al., 
2000) that are regarded as the major computational element for action control processes in 
the basal ganglia (Humphries et al., 2010; Bar-Gad et al., 2003). The GABAergic MSNs are 
involved in the selection of different actions (Bar-Gad et al., 2003) and possibly also in the 
suppression of responses (Bari & Robbins, 2013). Yet, the striatum seem to be particular 
important for proactive as opposed to reactive inhibition (Aron, 2011).Given this putative 
MSN-mediated suppression of response options it is possible that striatal GABA levels 
largely determine the efficacy of response inhibition processes. Yet, the role of striatal 
GABAergic neural transmission in response inhibition remains elusive.
We investigate the role of the striatal GABA system for response inhibition combining data 
obtained from magnetic resonance spectroscopy (MRS) with EEG correlates of response 
inhibition. Using EEG data, different response inhibition subprocesses can be distinguished: 
(i) a frontal-midline N2 component closely related to theta oscillations reflecting pre-motor 
processes like conflict monitoring or updating of the response program; and (ii) a P3 
component related to delta oscillations reflecting evaluative processing of the successful 
outcome of the inhibition (e.g. Huster et al., 2013; Beste et al., 2011; 2010). Beste et al. 
(2010) compared different basal ganglia diseases that differentially affect distinguishable 
basal ganglia subsystems. Using this comparative approach Beste et al. (2010) was able to 
show that especially the Nogo-N2 is affected by the nigro-striatal dopaminergic pathway, 
hence pointing to a role of striatal structures for cortical electrophysiological correlates of 
response inhibition. However, action selection in the striatum is largely determined by 
GABA is largely determined by GABA (Humphries et al., 2010). Recent results suggest that 
especially neural synchronization processes in striatal GABAergic medium spiny neurons 
are important for information encoding and behavioural control (Adler et al., 2013). It is 
therefore likely that striatal GABA levels strongly modulate response inhibition processes 
occurring in fronto-striatal networks. We hypothesize that higher striatal GABA levels come 
along with better performance in response inhibition; i.e. a lower rate of false alarms. False 
alarms are responses on Nogo stimulus, i.e., an error to withhold a response on Nogo 
stimuli. Striatal GABA concentrations largely determine striatal MSNs connectivity 
(Humphries et al., 2010) and it is the degree of connectivity in a neural assembly that is 
important for network synchronization (Kitano and Fukai, 2007). For the 
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electrophysiological processes we therefore hypothesize that the higher the striatal GABA 
level are correlated with the more synchronized electrophysiological oscillations in the delta 
or theta frequency bands and related response inhibition subprocesses.
Materials and Methods
Participants
The study sample consisted of forty right-handed healthy subjects (age 24.5 ± 5.9 years, 
range 20 – 30 years 10 females and 30 males) with no history of neurological or psychiatry 
disease and normal or corrected-to-normal vision. The study was approved by the Ethics 
committee of the Medical Faculty of the Ruhr-University Bochum, Germany.
Task
A standard Go/Nogo paradigm was used, similar to previous studies by our group (e.g. 
Ocklenburg et al., 2011; Beste et al., 2010). During the paradigm the words ‘PRESS’ and 
‘STOP’ (translating to DRÜCK and STOPP in German) were presented on a computer 
screen. Upon presentation of the ‘PRESS’ stimulus, subjects were required to respond via a 
custom-made button as fast as possible (Go-stimulus). Upon presentation of the ‘STOPP’ 
stimulus, the subjects were required to withhold a response (Nogo-stimulus). Subjects were 
asked to respond within 400 ms on the ‘DRÜCK’ stimulus and refrain from responding on 
the ‘STOPP’ stimulus. Each trial lasted 1200ms. To increase time pressure in order to 
strengthen response tendencies in trials exceeding this time, a feedback stimulus (1000 Hz, 
60 dB sound pressure level SPL) was given 1200 ms after the response, which was to be 
avoided by the subjects. The inter-trial interval (ITI) (time between two consecutive trials 
measured from the end of one trial to the beginning of the next trial) was jittered between 
1200 and 1400 ms. The short period for reaction together with short ITI induced a strong 
response tendency and hence a high rate of false alarms.
EEG recording and analysis
The EEG was recorded from 65 Ag/AgCl electrodes using the extended 10/20 system (Pivik 
et al., 1993) against a reference electrode located on electrode position Cz. The sampling 
rate of all recordings was 1 kHz. Electrode impedances were kept below 5 kΩ. The EEG was 
digitally filtered off-line using an IIR filer with filter band-width between 0.5 and 20 Hz. 
Horizontal and vertical eye-movements were corrected in the EEG using independent 
component analysis (ICA) (infomax algorithm). Artifact rejection procedures were applied 
twice: automatically, with an amplitude threshold of ±80 μV, and visually by rejecting all 
trials contaminated by technical artifacts. Before quantifying event-related potentials 
(ERPs), the current source density (CSD) of the signals was calculated to achieve a 
reference-free evaluation (Nunez et al., 1997 and Perrin et al., 1989) using the following 
parameters: order of splines (m = 4), and the maximum degree of the Legendre polynomials 
(n = 10), with a precision of 2.72−7. The data were segmented into 4096 ms long epochs. 
These long epochs were segmented to allow a reliable estimation of slow-oscillating 
frequencies in subsequent calculations of the phase-locking factor (PLF) (e.g. Beste et al., 
2012; Beste et al., 2011). Time point zero denoting the time point of Go and Nogo-stimulus 
delivery was placed in the middle. With this epoch length a reliable quantification of slow 
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oscillations (delta and theta frequencies) is possible. For the time domain analysis, baseline 
correction was applied in the interval ranging from -200 ms to stimulus presentation. For the 
time-frequency analysis, the baseline was set between -600 and -400 ms before stimulus 
presentation.
On trials denoting response inhibition the Nogo-N2 was defined as the most negative 
deflection within the range of 150 to 300 ms after stimulus onset. The Nogo-P3 was defined 
as the most positive deflection from 320 till 500 ms. Amplitudes of the Go-N2 and Go-P3 
were measured at the corresponding time point, where the Nogo component reached its 
maximum (Beste et al., 2010). The potentials were quantified at electrode FCz. As can be 
seen in the scalp topography plots on the Nogo-N2 and Nogo-P3 in Figure 3 the negativity 
for the Nogo-N2 is centered around electrode FCz and also the positivity of the Nogo-P3 is 
seen at this electrode site. The topography map on the phase-locking factor (PLF), which 
gives an estimate of neural synchronization processes also show that electrode FCz is the 
important electrode to analyze.
The PLF gives an estimate of the reliability of neural synchronization processes in time and 
frequency across trials (PLF; Roach & Mathalon, 2008; Tallon-Baudry et al., 2001). The 
PLF is independent of the signal’s amplitude (Kolev and Yordanova, 1997) and varies 
between 0 and 1, with a value of 1 indicating perfect phase-locking across trials (i.e., high 
reliability of neural synchronization processes in time and frequency across trials). To obtain 
the PLF we first ran a time-frequency analysis using complex Morlet wavelets. These 
wavelets w can be generated in the time domain for different frequencies, f, according to the 
equation:
where t is time, , σt is the wavelet duration, and . For analysis and 
TF-plots, a ratio of f0/σf = 5.5 was used, where f0 is the central frequency and σf is the width 
of the Gaussian shape in the frequency domain. The analysis was performed in the 
frequency range 0.1–20 Hz with a central frequency at 0.5 Hz intervals. For different f0, 
time and frequency resolutions can be calculated as 2 σt and 2 σf, respectively. σt and σf are 
related by the equation σt = 1/(2πσf). For each trial, the time-varying power in a given 
frequency band was calculated, which was obtained by squaring the absolute value of the 
convolution of the signal with the complex wavelet. The EEG data were collected outside 
the scanner in a different session. This was done to avoid the scanner artifacts that could 
impose problems in the analysis of the EEG data, especially when it comes to the time-
frequency decomposition and the quantification of the phase-locking factor.
MRS data acquisition and analysis
MRS data was acquired on a 3 T Philips Achieva whole-body scanner using a 32-channel 
head coil. Fast T2-weighted images were obtained in axial, coronal and sagittal planes to 
enable placement of a 30×30×25 mm3 MRS volume of interest (VOI) centered on the 
striatum. MRS spectra were acquired from VOIs placed in the left as well as the right 
striatum to rule out any laterality effects. MEGA-PRESS edited GABA spectra (Edden and 
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Barker, 2007; Mescher et al., 1998) were acquired from each VOI using the following 
parameters: repetition time (TR) = 2 s, echo time (TE) = 68 ms; a 15-ms editing pulse was 
applied either at 1.9 ppm (ON) or at 7.46 ppm (OFF); Segments of 16 ON and 16 OFF 
acquisitions of 2048 data points each and a spectral bandwidth of 2 kHz were interleaved 16 
times, resulting in a total of 16x16=256 averages per MEGA-PRESS scan; total acquisition 
time = 8.5 min. A total of 16 additional averages without water suppression were acquired, 
one at the beginning of each of the ON and OFF scan segments, and used as reference data 
for frequency and phase correction. LCModel (Provencher et al., 1993) (version 6.2-0R), 
which fits in vivo MR spectra as a linear combination of single metabolite “basis spectra”, 
was used for quantification (for details see suppl. material of Dydak et al., 2011). In 
particular, GABA was quantified from the MEGA-PRESS difference spectra using basis 
spectra created using density matrix simulations. Instead of using the in-built simplified 
GABA-fitting routine, we optimized the LCModel fitting parameters to allow the 
confounding macromolecule peak at 3.0 ppm to be largely fit by the flexible baseline 
function of LCModel (Dydak et al., 2011). While this additional degree of freedom results in 
slightly larger %SDs, it provides a more accurate estimation for pure GABA (Murdoch and 
Dydak 2011, Long et al. 2011, Dydak et al. 2011). All spectra had a linewidth of ≤10 Hz as 
determined by LCModel. All metabolite concentrations were computed as ratios to total 
creatine (tCr). The value of tCr for computing GABA/tCr was obtained from fitting the edit 
OFF spectrum of the MEGA-PRESS acquisition.
The fraction of gray matter (GM), white matter (WM) and cerebrospinal fluid (CSF) were 
calculated by superimposing the coordinates of the spectroscopy VOI on the high resolution 
T1-weighted images using the partial volume correction tool provided by N. Goulden and P. 
Mullins (http://biu.bangor.ac.uk/projects.php.en). The corresponding volume in the T1-
weighted data set was then segmented into GM, WM and CSF fractions using the VBM8 
toolbox (http://dbm.neuro.uni-jena.de/vbm/) as part of SPM8.
In addition to MEGA-PRESS spectra, regular short echo time Point REesolved 
Spectroscopy (PRESS) spectra (TR = 2 s, TE = 30 ms, 32 averages) were also obtained from 
the same VOIs and used for quantification of major metabolites including N-acetyl aspartate 
(NAA), total choline (tCho), tCr, myo-inositol (mI), and glutamate+glutamine (Glx). PRESS 
metabolite fits with a percentage standard deviation (%SD) value from LCModel over 20% 
were excluded from further analysis. For MEGA-PRESS, the corresponding %SD threshold 
was chosen to be 25% due to the flexible baseline approach. This threshold lies well within 
accepted standards used in GABA-MRS studies (e.g. Marjanska et al., 2013, Chowdhury et 
al., 2013, Silveri et al., 2013). However, the average %SD value for the GABA LCModel 
fits was 15.7 ± 3.5, and no GABA-edited spectra had to be excluded because of poor quality. 
A representative striatal GABA spectrum is displayed in Figure 1. Since no statistically 
significant differences were found within metabolite ratios between sides, prior to the 
regression analyses, the concentrations of different metabolites in the left and the right 
striatum were averaged across the left and right VOI for each subject (refer Figure 1).
The MRS data was collected prior to the conduction of the response inhibition experiment 
using EEG. Hence, MRS data does not reflect possible differential GABA levels for 
experimental trials in which response inhibition was successful and where response 
Quetscher et al. Page 5
Brain Struct Funct. Author manuscript; available in PMC 2016 November 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
inhibition was not successful. The GABA levels taken for the analysis reflect the general 
GABA level in the striatum; i.e., GABA levels were not determined in an event-related 
fashion for correct and incorrect Nogo-trials separately. This is because a reliable estimation 
of GABA concentrations requires several acquisition of the same volume. These several 
acquisitions cannot be performed in the time a single trial lasts. MRS data was integrated 
with the behavioural data and EEG data using linear regression analyses; i.e., we used the 
striatal GABA/tCr ratio as an independent variable to predict the degree of phase-locking 
and the amplitude values of the Nogo-N2 and Nogo-P3 signals. All significances for the 
correlations calculated were corrected using Bonferroni-Holm correction. The results 
presented are therefore controlled for possible type I errors.
Results
For descriptive statistics the mean and standard error of the mean (SEM) are given. For the 
left striatal VOI the GABA/tCr ratio was 0.224 ± 0.01 (SD = 0.05) and for the right striatal 
VOI 0.220 ± 0.01 (SD = 0.04) (GABA/tCr averaged over left and right striatal VOI was 
0.221 ± 0.01 (SD = 0.03). Assuming a grey matter creatine concentration of 6 mM (Pouwels 
and Frahm, 1998) allows for an estimate of the striatal GABA concentration of 1.34 ± 0.03 
mM, which is well in line with values reported for grey matter in general (Boer et al., 2011; 
Choi et al. 2006) and a thalamic volume of interest (Dydak et al. 2011).
For the behavioural data the rate of false alarms (i.e., percentage of Nogo trials on which a 
response occurred) in the Nogo condition was the main dependent variable of interest. The 
rate of false alarms was 13.87 ± 1.15. The regression analysis revealed a substantial inverse 
correlation (r = -.541; R2 = .292; p < .001) between averaged striatal GABA/tCr level and 
the rate of false alarms (refer Figure 2). There were no such correlations when using reaction 
times on Go and Nogo-trials as well as reaction time slowing after the inhibition of 
responses (all r < .2; p > .4).
The event-related potentials on Go and Nogo trials are shown in Figure 3 at electrode FCz. 
The N2 amplitudes differed between Go (−13.15 ± 1.35) and Nogo trials (−21.16 ± 2.08) 
(t39 = 6.37; p < .001). The same was evident for the P3, where the P3 was smaller on Go 
(10.92 ± 1.68), than on Nogo trials (30.19 ± 2.69) (t39 = −8.49; p < .001). The regression 
analyses revealed that neither the Nogo-N2 amplitude nor the Nogo-P3 amplitude were 
correlated with averaged striatal GABA/tCr levels (all r < .15; p > .4) (refer Figure 2D). 
Similarly, there was also no correlation for the Go amplitudes (all r < .2; p > .4; not 
scatterplots shown). However, since especially neuronal synchronization processes in striatal 
GABAergic MSNs are important for information encoding and behavioural control (Adler et 
al., 2013) we repeated the regression analyses after the calculation of the phase-locking 
factor (PLF). The PLF is independent of the amplitude of the EEG signal (e.g. Kolev and 
Yordanova, 1997) and therefore provides information about the neuronal synchronization 
processes that are unrelated to the above analysis of ERP amplitudes. Figure 4 shows the 
mean PLF on Nogo trials.
As can be seen in Figure 4A the PLF was highest in the theta frequency band around a 
frequency of 5 Hz, which agrees with literature (for review: Huster et al., 2013). The mean 
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PLF was 0.57 ± .02. The regression analysis using the averaged striatal GABA/tCr level 
revealed a strong positive correlation with the PLF (r = .612; R2 = .374 p < .001) as shown 
in Figure 4 in the Nogo-N2 time range. No correlation between averaged striatal GABA/tCr 
was evident in the Nogo-P3 time range at the 5Hz frequency (r = .142; p > .5) as well as 
other frequencies (all r < .12; p > .6). To test whether the gray matter fraction (GM%) of the 
MRS VOIs confounds the correlation between GABA/tCr and the response inhibition 
measures, we included the fraction of gray matter (GM%) (0.34 ± 0.006), white matter (WM
%) (0.58 ± 0.005) and cerebrospinal fluid (CSF%) (0.07 ± 0.004) as additional predictors to 
GABA/tCr in the regression analyses. This regression model also revealed a predictive 
effect of averaged GABA/tCr for the rate of false alarms (β = .541; t = 3.87; p < .001), while 
neither GM%, WM% nor CSF% explained the variance (all β < .042; t < −0.39; p > .9) 
(overall model: F(1,38) = 14.95; p < .001). The same was the case for PLF in the Nogo-N2 
range: There was a predictive effect of GABA/tCr (β = .612; t = 5.85; p < .001), but no 
effect of GM%, WM% and CSF% (all β < .141; t < 1.21; p > .2) (overall model: F(1,38) = 
34.27; p < .001).
Using the levels of metabolites obtained from the PRESS spectra (i.e., NAA, tCho, tCr, mI 
and Glx) there were generally no significant correlations with behavioural and 
neurophysiological parameters of response inhibition (all r < .3; p > .2). The total (induced) 
wavelet power on Go and Nogo trials at electrode FCz are shown in Figure 4B and C. Using 
the total wavelet power, there we no correlations with the striatal GABA/tCr levels or any 
other metabolite obtained from the PRESS spectra (all r < .15; p > .3). This again underlines 
the specificity of effects regarding the obtained associations with the synchronization 
parameter.
Discussion
In the current study we examined the relevance of striatal GABA levels for response 
inhibition processes. Striatal GABA levels were measured using MRS. While the data 
quality and variability of our MRS data lies well within the normal reported ranges for other 
brain regions, it should be noted that this is the first study reporting GABA MRS data 
acquired from the striatum, which is a particularly challenging brain area to achieve high 
quality MRS data from. Thus a direct comparison to other literature values, validating the 
interpretation of our results, is not available. Response inhibition processes were examined 
using a standard Go/Nogo paradigm in combination with EEG data that was integrated with 
the MRS data. The results show that striatal GABA levels were predictive for response 
inhibition performance; i.e., higher striatal GABA levels were related to a lower rate of false 
alarms in the Nogo condition and hence better response inhibition performance. The results 
are unbiased with respect to the fraction of GM, WM and CSF in the voxel. Other 
metabolites using the PRESS spectra (i.e., NAA, tCho, tCr, mI and Glx) did not predict 
parameters of response inhibition performance underlining the specificity of the results 
obtained for the GABA levels.
The results provide evidence for the assumption that the striatal GABAergic system, known 
to be involved in the selection of different actions through GABAergic neural transmission 
(Bar-Gad et al., 2003), is also involved in the suppression of responses. Previous studies in 
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neurodegenerative disorders (e.g. Beste et al., 2010) were not able to show a role of the 
GABAergic system unequivocally, since GABAergic alterations were confounded with 
alterations in the dopaminergic system, which is of known importance for response 
inhibition processes (for review: Bari & Robbins, 2013).
While Silveri et al. (2013) have previously shown that higher GABA levels in the anterior 
cingulate cortex are related to better response inhibition, our results show that this also true 
for striatal structures. In this regard the results of our study are also in line with recent 
findings by Caprioli et al., (2014) who demonstrated that reductions in glutamate 
decarboxylase in rats are related to impulsive behaviour. However, our results reveal three 
important aspects:
First, EEG measures are usually considered to as being sensitive only to cortical processes, 
but not sensitive to subcortical basal ganglia processes. The current results show that a large 
amount of variance in EEG data is explained by neurobiochemical parameters of the basal 
ganglia, suggesting that EEG measures are sensitive to ‘remote’ basal ganglia processes. 
This is underlined by studies in basal ganglia diseases showing that pathophysiological 
processes affecting the basal ganglia modulate cortical electrophysiological correlates of 
cognitive control and inhibition processes recorded using the EEG (e.g. Beste and Saft, 
2014; Beste et al., 2012; 2011; 2009). Possibly this effect arises as a consequence of the 
close functional and structural neuroanatomical connection between the prefrontal cortex 
and the basal ganglia (e.g. Chudasama and Robbins, 2006). Regarding the EEG data, striatal 
GABA levels were predictive for the PLF in the Nogo-N2 time window, but not in the 
Nogo-P3 time window. For the amplitudes of the Nogo-N2 and Nogo-P3 striatal GABA 
levels were not predictive.
Second, the striatal GABA system modulates the reliability of neural synchronization 
processes as reflected by the PLF and not the intensity of an electrophysiological process. 
As the strength of striatal MSN interconnectivity is largely determined by GABA 
(Humphries et al., 2010) and the degree of connectivity is known to determine network 
synchronization (e.g. Kitano and Fukai, 2007) as a major requirement for information 
encoding and behavioural control in the basal ganglia (Adler et al., 2013) it seems plausible 
that striatal GABA levels strongly modulate an electrophysiological measure of such neural 
synchronization processes. The importance of neural synchronization processes for response 
inhibition has also been shown by other electrophysiological studies (e.g. Beste et al., 2012; 
Swann et al., 2011). However, since the data structure obtained is necessarily correlative, it 
is also possible that altered neural synchronization processes at the cortical level may impact 
striatal GABA levels. Yet, in both cases the results stress the importance of the striatal 
GABAergic system for response inhibition. It is possible that GABA levels fluctuate 
between correct and incorrect Nogo trials, however, with current MRS methods it is not 
possible to measure GABA-levels in an event-related fashion.
Third, the results show that the striatal GABA system is only predictive for circumscribed 
electrophysiological subprocesses of response inhibition. It seems that striatal GABA levels 
modulate mechanisms reflecting pre-motor processes like conflict monitoring or updating of 
the response program (N2-related processes), but not mechanisms reflecting evaluative 
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processing of the successful outcome of the inhibition (P3-related processes) (e.g. Huster et 
al., 2013; Beste et al., 2011; 2010). The Nogo-N2 is more related to the motor aspects of 
response inhibition than is the case for the Nogo-P3 (e.g. Huster et al., 2013). Since the 
striatum plays a particularly important role in motor control and in the canceling and 
restraining of responses (Bari & Robbins, 2013; Bar-Gad et al., 2003), processes closely 
related to motor aspects of inhibition are more likely to be affected by GABA as a major 
basal ganglia neurotransmitter than processes related to subsequent evaluative processes.
The current study underlines the relevance of the GABAergic system for response inhibition 
processes. Besides these processes, other executive control functions like task switching, 
error monitoring and conflict processing have been shown to be modulated by striatal 
processes (Beste et al., 2014; van Schouwenburg et al., 2013; Willemssen et al., 2011; 
2009). It is therefore conceivable that psychophysiological correlates of these functions may 
also show modulations by the striatal GABAergic system.
A limitation of the study is that the menstrual cycle of the female participants and hence 
levels of steroid hormones which have a known impact on GABA levels (Harada et al., 
2011; Epperson et al., 2006) was not controlled for. Due to the low number of females in the 
present study it was also not possible to run reliable regression analyses using the factor 
‘sex’ as predictor in the regression models. A further limitation of the study may be the lack 
of a control region used for GABA measurements that may be useful to determine the 
specificity of effects obtained in this study. It should also be kept in mind that the estimated 
average tissue GABA concentration is the sum of metabolic GABA located in the cell body, 
within the synaptic cleft, coupled to GABA-receptors and at extrasynaptic sites (Rae, 2014). 
It is therefore unclear whether this metric is better considered to be a determinant of the 
strength of GABAergic inhibition or a reflection of net inhibitory activity. In the striatum 
GABAergic interneurons represent only a small fraction of the cell population (and therefore 
a small fraction of tissue volume) but appear to contain much higher concentrations of 
GABA than projection neurons, so it is not clear what striatal GABAergic neurons 
(overview: Tepper and Bolam, 2004) mainly drive the effects.
In summary, the study shows, using a novel combination of MRS data and time-frequency 
decomposed EEG data, that striatal GABA levels predict efficacy of response inhibition 
processes. To our knowledge this is the first study providing direct evidence for the 
relevance of the striatal GABAergic system for response inhibition functions and their 
cortical electrophysiological correlates in humans. Using EEG methods we show that striatal 
GABA seems to affect only specific subprocesses of response inhibition that are related to 
pre-motor inhibitory processes through the modulation of the reliability of neural 
synchronization processes.
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Figure 1. 
Representative MRS VOI placement in the right striatum (top) and the LCModel fits of 
MEGA-PRESS GABA spectrum (bottom left) and short TE PRESS spectrum (bottom right) 
acquired from the VOI.
Quetscher et al. Page 13
Brain Struct Funct. Author manuscript; available in PMC 2016 November 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 2. 
Scatterplot denoting the correlation between striatal GABA levels and the rate of false 
alarms in the Nogo condition.
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Figure 3. 
Grand average plot of Go and Nogo ERPs at electrode FCz. Time point zero denotes the 
time point of Go and Nogo stimulus presentation. The scalp topography plots denote the 
topography of the Nogo-N2 and Nogo-P3 at their peak maximum. Red lines denote Go-trials 
and blue lines denote Nogo trials. Red and blue shadings denote the standard deviation at 
each time point. The scatterplots denote the interrelation between striatal GABA levels and 
the Nogo-N2 amplitudes and Nogo-P3 amplitudes.
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Figure 4. 
(A) Grand average plot of the phase-locking factor (PLF) on Nogo trials at electrode FCz. 
Warm colors indicate high phase-locking, cold colors denotes low phase-locking. The 
scatterplots show the correlation between striatal GABA levels and the PLF in the Nogo-N2 
time window and the Nogo-P3 time window. Black lines linking the scatter plot with the 
relative time point (region in the PL-plot) indicate the time point from which the PL for the 
N2 and the P3 component was extracted. Warm colours in the maps denote electrode sites 
where the phase-locking factor was high, cold colour denote electrode sites where the phase-
locking factor was low. (B) Time frequency plot denoting the total (induced) wavelet power 
at electrode FCz for Go trials. (C) Time frequency plot denoting the total (induced) wavelet 
power at electrode FCz for Nogo trials.
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